Syndrome of inappropriate antidiuretic hormone secretion following immune effector cell-associated neurotoxicity syndrome during blinatumomab therapy: a case report
{{output}}
Background: Blinatumomab (BLINA) causes immune-related toxicities, such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome (ICANS). Although hyponatremia associated with interleukin (IL)-6-med... ...
